ANGELA TRACKWELL: Open Payments
NPI 1558992156 · GREENFIELD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 57 payments from 17 companies in 2025. Trend: 2023 $190 · 2024 $1,076 · 2025 $1,083
Food & beverage: $1,083
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $230 |
| AstraZeneca Pharmaceuticals LP | 6 | $135 |
| Lilly USA, LLC | 5 | $97 |
| Astellas Pharma US Inc | 4 | $89 |
| Otsuka America Pharmaceutical, Inc. | 4 | $87 |
| PFIZER INC. | 5 | $85 |
| Amgen Inc. | 4 | $60 |
| Exact Sciences Corporation | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| GlaxoSmithKline, LLC. | 2 | $37 |
Products named: AIRSUPRA, Veozah, MOUNJARO, Ozempic, ELIQUIS, JARDIANCE, ABILIFY MAINTENA, The Cologuard Plus Collection Kit.
Industry payments across IN — which companies pay providers there.
